Use of venovenous ECMO for neonatal and pediatric ECMO: a decade of experience at a tertiary children’s hospital

• DOI: 10.1007/s00383-018-4225-5
• Publication Date: 2018-01-18T06:27:39Z
• Authors: Jennifer L. Carpe...; Yangyang R. Yu; Darrell L. Cass; Oluyinka O. Olutoye; James A. Thomas; Cole Burgman; Caraciolo J. Fern...; Timothy C. Lee
• Keywords: Male; Infant, Newborn; Infant; Hospitals, Pediatric; Intensive Care Units, Pediatric; Texas; Brain Ischemia; Catheterization; 3. Good health; Cohort Studies; Tertiary Care Centers; 03 medical and health sciences; Extracorporeal Membrane Oxygenation; 0302 clinical medicine; Child, Preschool; Intensive Care Units, Neonatal; Humans; Female; Child; Intracranial Hemorrhages; Retrospective Studies

Advances in extracorporeal membrane oxygenation (ECMO) have led to increased use of venovenous (VV) ECMO in the pediatric population. We present the evolution and experience of pediatric VV ECMO at a tertiary care institution.A retrospective cohort study from 01/2005 to 07/2016 was performed, comparing by cannulation mode. Survival to discharge, complications, and decannulation analyses were performed.In total, 160 patients (105 NICU, 55 PICU) required 13 ± 11 days of ECMO. VV cannulation was used primarily in 83 patients with 64% survival, while venoarterial (VA) ECMO was used in 77 patients with 54% survival. Overall, 74% of patients (n = 118) were successfully decannulated; 57% survived to discharge. VA ECMO had a higher rate of intra-cranial hemorrhage than VV (22 vs 9%, p = 0.003). Sixteen VA patients (21%) had radiographic evidence of a cerebral ischemic insult. No cardiac complications occurred with the use of dual-lumen VV cannulas. There were no differences in complications (p = 0.40) or re-operations (p = 0.85) between the VV and VA groups.Dual-lumen VV ECMO can be safely performed with appropriate image guidance, is associated with a lower rate of intra-cranial hemorrhage, and may be the preferred first-line mode of ECMO support in appropriately selected NICU and PICU patients.II.